Q2 2020 Radius Health Inc Earnings Call

10/8/2020 8:30

שיחת ועידה Radius Health Inc

Radius Health Inc Conference call will be held on 10/08/2020. During the earnings conference call's session Radius Health Inc will provide updated information and financial status.
Conference call is also referred to as: teleconference call or audio conference bridge. Conferencing service is provided in house or as cloud based teleconference service.
In order to join the audio conferencing dial conference bridge and key in the PIN code, Contact Radius Health Inc for this information
Schedule an online conference with QCONF conference service and get 5 free calls with online conferencing.
Unless otherwise provided in this report, all references in this report to "we," "us," "our company," "our," or the "Company" refer to Radius Health, Inc. Overview We are a science-driven biopharmaceutical company that is committed to developing innovative therapeutics in the areas of osteoporosis, oncology and endocrine diseases. Our lead product candidate, the investigational drug abaloparatide for subcutaneous injection, has completed Phase 3 development for potential use in the reduction of fracture risk in postmenopausal women with osteoporosis and is currently under regulatory review in Europe. Our clinical pipeline also includes an investigational abaloparatide transdermal patch for potential use in osteoporosis and the investigational drug RAD1901 for potential use in hormone-driven, or hormone-resistant, breast cancer, and vasomotor symptoms in postmenopausal women.    
קרא עוד שיחת ועידה

Radius Health Inc (RDUS)

950 Winter Street, Waltham Massachusetts 02451, United States